Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913823039> ?p ?o ?g. }
- W2913823039 endingPage "1724" @default.
- W2913823039 startingPage "1718" @default.
- W2913823039 abstract "The first-line eradication rate of standard triple therapy for Helicobacter pylori infection has declined to <80%, and alternative therapies with >90% success rates are needed. Inconsistent eradication rates were reported for proton pump inhibitor- and amoxicillin-containing high-dose dual therapy.We performed a prospective, randomized controlled study to assess the efficacy of esomeprazole- and amoxicillin-containing high-dose dual therapy and investigated the influencing clinical factors.We recruited 240/278 eligible H. pylori-infected patients after exclusion. They were randomly assigned to 14 day high-dose dual therapy (esomeprazole 40 mg three times daily and amoxicillin 750 mg four times daily for 14 days; EA group) or 7 day non-bismuth quadruple therapy (esomeprazole 40 mg twice daily, clarithromycin 500 mg twice daily, amoxicillin 1 g twice daily and metronidazole 500 mg twice daily for 7 days; EACM group). Urea breath tests were followed up 8 weeks later.The eradication rates for the EA and EACM groups were 91.7% (95% CI = 85.3%-96.0%) and 86.7% (95% CI = 79.3%-92.2%) (P = 0.21) in ITT analysis; and 95.7% (95% CI = 90.2%-98.6%) and 92.0% (95% CI = 85.4%-96.3%) (P = 0.26) in PP analysis. The adverse event rates were 9.6% versus 23.0% in the two groups (P = 0.01). The H. pylori culture positivity rate was 91.8%. The antibiotic resistance rates were amoxicillin, 0%; clarithromycin, 14.6%; and metronidazole, 33.7%.A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy achieves a high eradication rate as first-line anti-H. pylori therapy, comparable to that with 7 day non-bismuth quadruple therapy but with fewer adverse events." @default.
- W2913823039 created "2019-02-21" @default.
- W2913823039 creator A5014376217 @default.
- W2913823039 creator A5024318722 @default.
- W2913823039 creator A5035027289 @default.
- W2913823039 creator A5048625267 @default.
- W2913823039 creator A5049853138 @default.
- W2913823039 creator A5052266233 @default.
- W2913823039 creator A5052418430 @default.
- W2913823039 creator A5060072109 @default.
- W2913823039 creator A5063800590 @default.
- W2913823039 creator A5072098856 @default.
- W2913823039 creator A5076367211 @default.
- W2913823039 creator A5076554831 @default.
- W2913823039 creator A5077293484 @default.
- W2913823039 date "2019-02-14" @default.
- W2913823039 modified "2023-10-16" @default.
- W2913823039 title "A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial" @default.
- W2913823039 cites W1562597487 @default.
- W2913823039 cites W1601207235 @default.
- W2913823039 cites W1987346998 @default.
- W2913823039 cites W1988342010 @default.
- W2913823039 cites W1992827772 @default.
- W2913823039 cites W1993069856 @default.
- W2913823039 cites W1997115882 @default.
- W2913823039 cites W2014180406 @default.
- W2913823039 cites W2042045508 @default.
- W2913823039 cites W2050132242 @default.
- W2913823039 cites W2052603050 @default.
- W2913823039 cites W2065860180 @default.
- W2913823039 cites W2076901617 @default.
- W2913823039 cites W2086515507 @default.
- W2913823039 cites W2098162091 @default.
- W2913823039 cites W2104990720 @default.
- W2913823039 cites W2120771508 @default.
- W2913823039 cites W2125173799 @default.
- W2913823039 cites W2128290460 @default.
- W2913823039 cites W2132041753 @default.
- W2913823039 cites W2136210283 @default.
- W2913823039 cites W2145166513 @default.
- W2913823039 cites W2151678454 @default.
- W2913823039 cites W2153165213 @default.
- W2913823039 cites W2159142230 @default.
- W2913823039 cites W2164497230 @default.
- W2913823039 cites W2166261298 @default.
- W2913823039 cites W2290736004 @default.
- W2913823039 cites W2369554056 @default.
- W2913823039 cites W2429963029 @default.
- W2913823039 cites W2613485273 @default.
- W2913823039 cites W2805398543 @default.
- W2913823039 cites W2898433127 @default.
- W2913823039 doi "https://doi.org/10.1093/jac/dkz046" @default.
- W2913823039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30768161" @default.
- W2913823039 hasPublicationYear "2019" @default.
- W2913823039 type Work @default.
- W2913823039 sameAs 2913823039 @default.
- W2913823039 citedByCount "63" @default.
- W2913823039 countsByYear W29138230392019 @default.
- W2913823039 countsByYear W29138230392020 @default.
- W2913823039 countsByYear W29138230392021 @default.
- W2913823039 countsByYear W29138230392022 @default.
- W2913823039 countsByYear W29138230392023 @default.
- W2913823039 crossrefType "journal-article" @default.
- W2913823039 hasAuthorship W2913823039A5014376217 @default.
- W2913823039 hasAuthorship W2913823039A5024318722 @default.
- W2913823039 hasAuthorship W2913823039A5035027289 @default.
- W2913823039 hasAuthorship W2913823039A5048625267 @default.
- W2913823039 hasAuthorship W2913823039A5049853138 @default.
- W2913823039 hasAuthorship W2913823039A5052266233 @default.
- W2913823039 hasAuthorship W2913823039A5052418430 @default.
- W2913823039 hasAuthorship W2913823039A5060072109 @default.
- W2913823039 hasAuthorship W2913823039A5063800590 @default.
- W2913823039 hasAuthorship W2913823039A5072098856 @default.
- W2913823039 hasAuthorship W2913823039A5076367211 @default.
- W2913823039 hasAuthorship W2913823039A5076554831 @default.
- W2913823039 hasAuthorship W2913823039A5077293484 @default.
- W2913823039 hasBestOaLocation W29138230391 @default.
- W2913823039 hasConcept C126322002 @default.
- W2913823039 hasConcept C168563851 @default.
- W2913823039 hasConcept C197934379 @default.
- W2913823039 hasConcept C202953159 @default.
- W2913823039 hasConcept C2776409635 @default.
- W2913823039 hasConcept C2776962512 @default.
- W2913823039 hasConcept C2777396551 @default.
- W2913823039 hasConcept C2778204628 @default.
- W2913823039 hasConcept C2779708577 @default.
- W2913823039 hasConcept C2781025758 @default.
- W2913823039 hasConcept C2781413609 @default.
- W2913823039 hasConcept C3019249092 @default.
- W2913823039 hasConcept C501593827 @default.
- W2913823039 hasConcept C71924100 @default.
- W2913823039 hasConcept C86803240 @default.
- W2913823039 hasConcept C89423630 @default.
- W2913823039 hasConcept C90924648 @default.
- W2913823039 hasConceptScore W2913823039C126322002 @default.
- W2913823039 hasConceptScore W2913823039C168563851 @default.
- W2913823039 hasConceptScore W2913823039C197934379 @default.
- W2913823039 hasConceptScore W2913823039C202953159 @default.